Results 301 to 310 of about 1,257,254 (358)

[Chronic kidney failure].

Naika. Internal medicine, 1970
N, Mimura, T, Takuma, H, Kaneda, H, Nihei   +3 more
openaire   +3 more sources

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

New England Journal of Medicine, 2021
Deepak L Bhatt, Michael Szarek, Bertram Pitt   +2 more
exaly  

Chronic Kidney Disease and Kidney Failure

Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional, 2007
openaire   +3 more sources

Dapagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2020
Hiddo J Lambers Heerspink, Bergur V Stefansson, Ricardo C Correa-Rotter   +2 more
exaly  

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2020
George Bakris, Rajiv Agarwal, Stefan D Anker   +2 more
exaly  

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2023
exaly  

[Chronic kidney failure].

Nihon rinsho. Japanese journal of clinical medicine, 1976
K, Kobayashi, M, Shibata, K, Maeda, K, Shimizu, A, Saitoo   +4 more
openaire   +1 more source

Effects of Allopurinol on the Progression of Chronic Kidney Disease

New England Journal of Medicine, 2020
Sunil V Badve, Neil Boudville, Alan Cass
exaly  

[Anemia and chronic kidney failure].

Vnitrni lekarstvi, 2011
Anaemia is a common manifestation ofa chronic kidney failure. It is caused by a relative shortage oferythropoetine (EPO) and iron deficite with its metabolism defect. The most important factor in the pathogenesis of iron metabolism defects is hepcidin. Hepcidin maintains the iron homeostasis in the organism. The therapy of renal anaemia is based on the
openaire   +1 more source

Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes

New England Journal of Medicine, 2014
Lakhmir S Chawla
exaly